Pancreatic Cancer
News
Abraxane®/Gemzar® Promising in Pancreatic Cancer
(04/17/2008)
The chemotherapy combination consisting of Abraxane® (paclitaxel) and Gemzar® (gemcitabine) appears promising for the treatment of advanced pancreatic cancer. These results were recently presented at the 2008 annual meeting of the American Association for Cancer Research.
Addition of Erbitux® Does Not Improve Outcomes in Pancreatic Cancer
(04/08/2008)
The addition of the targeted agent Erbitux® (cetuximab) to the chemotherapy combination Gemzar® (gemcitabine) and Platinol® (cisplatin) does not improve outcomes compared with chemotherapy only in advanced pancreatic cancer. These results were recently published in Lancet Oncology.
Addition of Gemzar® in Early Pancreatic Cancer May Modestly Improve Survival
(03/05/2008)
The addition of Gemzar® (gemcitabine) to 5-fluorouracil may modestly improve survival among patients with early pancreatic cancer. Further study is necessary, however, to determine the true benefit of Gemzar in early pancreatic cancer. These results were published in the Journal of the American Medical Association.
Being Overweight Associated with Increased Risk of Several Cancers
(02/19/2008)
Excess bodyweight increases the risk of developing several types of cancer, according to results recently published in The Lancet.
Radiation Therapy May Be Effective in Early Pancreatic Cancer
(02/11/2008)
Radiation therapy may improve survival among patients diagnosed with early-stage pancreatic cancer. These findings were recently published in the journal Cancer.
More
Pancreatic Cancer
Cancer News...